Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles...

FDA Recall #D-0295-2022 — Class I — November 30, 2021

Recall #D-0295-2022 Date: November 30, 2021 Classification: Class I Status: Ongoing

Product Description

Lidocaine Hydrochloride, Topical Solution USP, 4% (40 mg/mL), packaged in 50 mL screw cap bottles, Rx Only, Manufactured by Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-997-64

Reason for Recall

Superpotent Drug

Recalling Firm

Teligent Pharma, Inc. — Buena, NJ

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

6,816 bottles

Distribution

Distributed to a wholesaler in CO who further distributed Nationwide in the USA

Code Information

Lot #: 16345, Exp. Date 01/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated